Harvard Bioscience, Inc. (HBIO)
0.7414
-0.02
(-3.03%)
USD |
NASDAQ |
Dec 11, 13:46
Harvard Bioscience Total Liabilities (Quarterly): 63.92M for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Bruker Corp. | 3.942B |
| Azenta, Inc. | 330.70M |
| Precipio, Inc. | 7.404M |
| Bionano Genomics, Inc. | 29.26M |
| Kestra Medical Technologies Ltd. | 82.14M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 77.99M |
| Shareholders Equity (Quarterly) | 14.07M |
| Debt to Equity Ratio | 3.041 |
| Current Ratio | 0.8053 |
| Net Debt Paydown Yield | -1.36% |